<SEC-DOCUMENT>0001178913-25-000181.txt : 20250121
<SEC-HEADER>0001178913-25-000181.hdr.sgml : 20250121
<ACCEPTANCE-DATETIME>20250121083853
ACCESSION NUMBER:		0001178913-25-000181
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250121
DATE AS OF CHANGE:		20250121

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RADCOM LTD
		CENTRAL INDEX KEY:			0001016838
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER PERIPHERAL EQUIPMENT, NEC [3577]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-55901
		FILM NUMBER:		25540557

	BUSINESS ADDRESS:	
		STREET 1:		24 RAOUL WALLENBERG STREET
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			69719
		BUSINESS PHONE:		2123108007

	MAIL ADDRESS:	
		STREET 1:		26 RAOUL WALLENBERG STREET
		STREET 2:		TEL AVIV 69719
		CITY:			ISREAL
		STATE:			L3
		ZIP:			00000

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Zisapel Michael
		CENTRAL INDEX KEY:			0002026830
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	MAIL ADDRESS:	
		STREET 1:		9 HAHATZAV STREET (RAMAT EFAL)
		CITY:			RAMAT GAN
		STATE:			L3
		ZIP:			5290517
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>SCHEDULE 13D/A</submissionType>
<previousAccessionNumber>0001104659-24-071115</previousAccessionNumber>
<filerInfo>
<filer>
<filerCredentials>
<cik>0002026830</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>


</filerInfo>
</headerData>
<formData>
<coverPageHeader>
<amendmentNo>2</amendmentNo>
<securitiesClassTitle>Ordinary Shares par value NIS 0.20 per shares</securitiesClassTitle>
<dateOfEvent>01/17/2025</dateOfEvent>
<previouslyFiledFlag>false</previouslyFiledFlag>
<issuerInfo>
<issuerCIK>0001016838</issuerCIK>
<issuerCUSIP>M81865111</issuerCUSIP>
<issuerName>RadCom Ltd</issuerName>
<address>
<com:street1>24 RAOUL WALLENBERG STREET</com:street1>
<com:city>TEL-AVIV</com:city>
<com:stateOrCountry>L3</com:stateOrCountry>
<com:zipCode>6971920</com:zipCode>
</address>
</issuerInfo>
<authorizedPersons>
<notificationInfo>
<personName>MICHAEL ZISAPEL</personName>
<personPhoneNum>972-547369030</personPhoneNum>
<personAddress>
<com:street1>24 RAOUL WALLENBERG STREET</com:street1>
<com:city>TEL-AVIV</com:city>
<com:stateOrCountry>L3</com:stateOrCountry>
<com:zipCode>6971920</com:zipCode>
</personAddress>
</notificationInfo>
</authorizedPersons>
</coverPageHeader>
<reportingPersons>
<reportingPersonInfo>
<reportingPersonCIK>0002026830</reportingPersonCIK>
<reportingPersonName>Zisapel Michael</reportingPersonName>
<memberOfGroup>a</memberOfGroup>
<fundType>OO</fundType>
<citizenshipOrOrganization>L3</citizenshipOrOrganization>
<soleVotingPower>2042645</soleVotingPower>
<sharedVotingPower>542147</sharedVotingPower>
<soleDispositivePower>2042645</soleDispositivePower>
<sharedDispositivePower>542147</sharedDispositivePower>
<aggregateAmountOwned>1302295</aggregateAmountOwned>
<isAggregateExcludeShares>N</isAggregateExcludeShares>
<percentOfClass>8.2</percentOfClass>
<typeOfReportingPerson>IN</typeOfReportingPerson>
<commentContent>(7)(8)(9)(10)(11)(13) See Item 5.&#13;
(7)(9)(11) Includes options to acquire 19,798 Ordinary Shares exercisable currently or within 60 days of January 17, 2025</commentContent>
</reportingPersonInfo>
<reportingPersonInfo>
<reportingPersonNoCIK>Y</reportingPersonNoCIK>
<reportingPersonName>KLIL ZISAPEL</reportingPersonName>
<memberOfGroup>a</memberOfGroup>
<fundType>OO</fundType>
<citizenshipOrOrganization>L3</citizenshipOrOrganization>
<soleVotingPower>2042646</soleVotingPower>
<sharedVotingPower>542147</sharedVotingPower>
<soleDispositivePower>2042646</soleDispositivePower>
<sharedDispositivePower>542147</sharedDispositivePower>
<aggregateAmountOwned>1302296</aggregateAmountOwned>
<isAggregateExcludeShares>N</isAggregateExcludeShares>
<percentOfClass>8.2</percentOfClass>
<typeOfReportingPerson>IN</typeOfReportingPerson>
<commentContent>(7)(8)(9)(10)(11)(13) See Item 5.&#13;
(7)(9)(11) Includes options to acquire 19,799 Ordinary Shares exercisable currently or within 60 days of January 17, 2025</commentContent>
</reportingPersonInfo>
</reportingPersons>
<items1To7>
<item1>
<securityTitle>Ordinary Shares par value NIS 0.20 per shares</securityTitle>
<issuerName>RadCom Ltd</issuerName>
<issuerPrincipalAddress>
<com:street1>24 RAOUL WALLENBERG STREET</com:street1>
<com:city>TEL-AVIV</com:city>
<com:stateOrCountry>L3</com:stateOrCountry>
<com:zipCode>6971920</com:zipCode>
</issuerPrincipalAddress>
</item1>
<item2>
<filingPersonName>1. Michael Zisapel&#13;
2. Klil Zisapel</filingPersonName>
<principalBusinessAddress>24 Raoul Wallenberg Street, Building C, Tel Aviv 6971920 Israel</principalBusinessAddress>
<principalJob>1. Mr. Zisapel is a physician at Tel Aviv Sourasky Medical Center. The business address of Mr. Zisapel is 24 Raoul Wallenberg Street, Tel-Aviv, 6971920 Israel. &#13;
2. Ms. Zisapel is a writer. The business address of Ms. Zisapel is Vitkin 3, Apartment 5, Tel-Aviv 6347403, Israel.</principalJob>
<hasBeenConvicted>During the past five years, neither Mr. Zisapel nor Ms. Zisapel has been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors).</hasBeenConvicted>
<convictionDescription>During the past five years, neither Mr. Zisapel nor Ms. Zisapel has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which such person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding of any violation with respect to such laws.</convictionDescription>
<citizenship>Mr. Zisapel and Ms. Zisapel are each citizens and residents of Israel.</citizenship>
</item2>
<item3>
<fundsSource>The Reporting Persons acquired the securities reported on this Schedule 13D in connection with the illness and subsequent death of their father, Zohar Zisapel, co-founder, member of the Board of Directors and major shareholder of the Issuer, which occurred on May 19, 2023.&#13;
&#13;
On May 18, 2023, Zohar Zisapel transferred without consideration 50% of the ownership interests in each of Michael &amp; Klil Holdings (93) Ltd. and Lomsha Ltd. to each of the Reporting Persons, through which the Reporting Persons each hold an indirect ownership interest in an aggregate of  271,074 Ordinary Shares of the Issuer and shared voting and dispositive power with respect to an aggregate of 542,147 Ordinary Shares of the Issuer as the 50% owners of such entities.&#13;
&#13;
A probate was issued by the Israeli Registrar for Matters of Succession on August 4, 2023, according to which Zohar Zisapel's assets were divided 50% to Mr. Zisapel and 50% to Ms. Zisapel. Following the completion of certain transfer requirements, the Reporting Persons now own an aggregate of 2,624,904 Ordinary Shares of the Issuer effective as of January 17, 2025 (including options to acquire 39,597 Ordinary Shares exercisable currently or within 60 days of January 17, 2025).&#13;
&#13;
No funds or other consideration was used by the Reporting Persons to acquire the shares subject hereof, and no funds or other consideration were borrowed or otherwise obtained for the purpose of acquiring, holding, trading, or voting the shares subject hereof.</fundsSource>
</item3>
<item5>
<percentageOfClassSecurities>Mr. Zisapel beneficially owns 1,302,295 Ordinary Shares of the Issuer, consisting of (i) 1,011,424 Ordinary Shares held directly by Mr. Zisapel, and (ii) 271,074 Ordinary Shares that are held indirectly by Mr. Zisapel through his 50% ownership in each of Lomsha Ltd., an Israeli company, and Michael &amp; Klil Holdings (93) Ltd., an Israeli company and (iii) options to acquire 19,798 Ordinary Shares exercisable within 60 days. Based on 15,881,940 Ordinary Shares of the Issuer issued and outstanding as of November 26, 2024, the Ordinary Shares beneficially owned by Mr. Zisapel represent approximately 8.2% of the Ordinary Shares of the Issuer issued and outstanding.&#13;
&#13;
Ms. Zisapel beneficially owns 1,302,296 Ordinary Shares of the Issuer, consisting of (i) 1,011,424 Ordinary Shares held directly by Ms. Zisapel and (ii) 271,074 Ordinary Shares that are held indirectly by Ms. Zisapel through her 50% ownership in each of Lomsha Ltd., an Israeli company, and Michael &amp; Klil Holdings (93) Ltd., an Israeli company and (iii) options to acquire 19,799 Ordinary Shares exercisable within 60 days.  Based on 15,881,940 Ordinary Shares of the Issuer issued and outstanding as of November 26, 2024, the Ordinary Shares beneficially owned by Ms. Zisapel represent approximately 8.2% of the Ordinary Shares of the Issuer issued and outstanding.</percentageOfClassSecurities>
<numberOfShares>Mr. Zisapel has sole voting and dispositive power over 2,042,645 Ordinary Shares mutually held by the Reporting Persons in security bank accounts, and has shared voting and dispositive power over an aggregate of 542,147 Ordinary Shares owned by Lomsha Ltd and Michael &amp; Klil Holdings (93) Ltd., in each of which Mr. Zisapel owns a 50% interest.&#13;
&#13;
Ms. Zisapel has sole voting and dispositive power over 2,042,646 Ordinary Shares mutually held by the Reporting Persons in security bank accounts, and has shared voting and dispositive power over an aggregate of 542,147 Ordinary Shares owned by Lomsha Ltd and Michael &amp; Klil Holdings (93) Ltd., in each of which Ms. Zisapel owns a 50% interest.</numberOfShares>
<transactionDesc>During the last 60 days, the Reporting Persons have affected the following transactions in the Ordinary Shares of the Issuer:&#13;
&#13;
Date of Transaction: January 15, 2025&#13;
Number of Shares: 7,133&#13;
Price Per Share: $12.87&#13;
Type of Transaction: Sale&#13;
&#13;
Date of Transaction: January 16, 2025&#13;
Number of Shares: 10,000&#13;
Price Per Share: $13.38&#13;
Type of Transaction: Sale&#13;
&#13;
Date of Transaction: January 17, 2025&#13;
Number of Shares: 10,000&#13;
Price Per Share: $13.89&#13;
Type of Transaction: Sale&#13;
&#13;
In addition to the transactions reported above, the Reporting Persons sold 150,264 shares of the Issuer's common stock approximately 2 months ago, representing 0.94% of the Issuer's outstanding shares at that time. Together with the 27,133 shares sold within the past 60 days, the Reporting Persons' total sales during the past 5 months represent 1% of the Issuer's total outstanding shares.</transactionDesc>
</item5>
<item7>
<filedExhibits>99.1   Joint Filing Agreement</filedExhibits>
</item7>
</items1To7>
<signatureInfo>
<signaturePerson>
<signatureReportingPerson>Zisapel Michael</signatureReportingPerson>
<signatureDetails>
<signature>/s/ Michael Zisapel</signature>
<title>MICHAEL ZISAPEL</title>
<date>01/20/2025</date>
</signatureDetails>
</signaturePerson>
<signaturePerson>
<signatureReportingPerson>KLIL ZISAPEL</signatureReportingPerson>
<signatureDetails>
<signature>/s/ Klil Zisapel</signature>
<title>KLIL ZISAPEL</title>
<date>01/20/2025</date>
</signatureDetails>
</signaturePerson>
</signatureInfo>
</formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: zk-global
         Document created using Broadridge PROfile 24.12.1.5274
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Exhibit 99.1</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">JOINT FILING AGREEMENT</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 21.6pt; line-height: 1.25;">In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below
        agree to the joint filing on behalf of them of an Amendment to statement on Schedule 13D (including amendments thereto) with respect to the Ordinary Shares, NIS 0.20 par
          value per share, of RADCOM Ltd., and further agree that this Joint Filing Agreement be included as Exhibit 99.1.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 21.6pt; line-height: 1.25;">In evidence thereof, the undersigned hereby execute this Joint Filing Agreement as of&#160;January 20, 2025.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="zca949640a0ed4b0782fc644d6091b22e">

            <tr>
              <td style="width: 50.00%;"><br>
              </td>
              <td style="width: 50.00%;"><u><font style="font-style: italic;">/s/ Michael Zisapel</font><br>
                </u></td>
            </tr>
            <tr>
              <td style="width: 50.00%;"><br>
              </td>
              <td style="width: 50.00%;">Michael Zisapel</td>
            </tr>
            <tr>
              <td style="width: 50.00%;"><br>
              </td>
              <td style="width: 50.00%;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 50.00%;"><br>
              </td>
              <td style="width: 50%; font-style: italic;"><u>/s/ Klil Zisapel<br>
                </u></td>
            </tr>
            <tr>
              <td style="width: 50.00%;"><br>
              </td>
              <td style="width: 50.00%;">Klil Zisapel</td>
            </tr>

        </table>
      </div>
      <div><br>
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><br>
      </div>
      <br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
